| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 556,342 | 524,343 | 407,331 | 535,609 | | Cost of Revenue | 472,641 | 448,961 | 392,322 | 499,753 | | | Gross Profit | 83,701 | 75,382 | 15,009 | 35,856 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 46,863 | 50,185 | 32,676 | 38,113 | | Non Recurring | (1,821) | 20,068 | 8,037 | 170,478 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,597 | 5,129 | (25,704) | (172,735) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 400,725 | (955) | 121,055 | (2,371) | | Earnings Before Interest And Taxes | 332,155 | 4,174 | 95,351 | (175,106) | | Interest Expense | (76,519) | 41,347 | 35,172 | 36,356 | | Income Before Tax | 408,674 | (37,173) | 60,179 | (211,462) | | Income Tax Expense | 178,523 | (34,221) | 11,894 | (12,774) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 230,151 | (2,952) | 48,285 | (198,688) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 230,151 | (2,952) | 48,285 | (198,688) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $230,151 | ($2,952) | $48,285 | ($198,688) |
|
0.02% Nasdaq 0.00%
Income Statement
